In this report, the EMEA Point of Care (PoC) Molecular Diagnostics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Point of Care (PoC) Molecular Diagnostics for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Point of Care (PoC) Molecular Diagnostics market competition by top manufacturers/players, with Point of Care (PoC) Molecular Diagnostics sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Bayer Corporation
Roche Diagnostics
Sysmex Corporation
Abaxis
Abbott Laboratories
BioMerieux SA
Bio-Rad Laboratories
Danaher Corporation
OraSure Technologies

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Polymerase Chain Reaction (Real Time PCR)
In Situ Hybridization
Chips and Microarrays
Mass Spectrometry
Sequencing
Isothermal Amplification
Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospitals
Diagnostic Laboratories
Research & Academic Laboratories

If you have any special requirements, please let us know and we will offer you the report as you want.